VANCOUVER, BC, January 25, 2018 / – Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on creating innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has signed an agreement with True Life Home Health LLC in Texas to provide Reliq’s iUGO Care chronic care management, remote patient monitoring and telemedicine platform to their over 2,000 home care clients. This contract will generate over $1,200,000 USD in recurring annual revenue at full deployment. Patient enrolment will begin in February 2018. In total Reliq now has contracts in place to provide its iUGO Care platform to over 50,000 patients, representing over $30 Million USD in recurring annual revenue at full deployment.
“We are very pleased to be working with True Life Home Health to deliver high quality care to patients in the home,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Reliq’s iUGO Care remote patient monitoring system quickly and easily collects sophisticated health data from patients in their own homes. Our secure, cloud-based care collaboration platform provides the clinical care team, patient and family members with real-time access to patient health information including trends over time. This helps the care team identify patients whose condition is becoming unstable and intervene early, before a serious complication develops. Patients and their loved ones are able to clearly see how compliance with prescribed medication and lifestyle changes affect the patient’s health status, improving patient engagement and patient- and family-reported satisfaction. The iUGO Care virtual care platform was designed to reduce readmissions and improve health outcomes. Our technology allows patients to receive high quality care from the comfort of their own homes, reducing the cost of care delivery and increasing patient and family satisfaction.”
“True Life Home Health is committed to providing high quality care to complex chronic disease patients in the comfort of their own homes,” said Sonia Anciso, President. “We are excited to be working with Reliq Health to support our care providers in their day-to-day workflow, freeing up more time for patient care. We feel that incorporating cutting edge technologies like the iUGO Care platform will help True Life improve health outcomes and reduce overall healthcare costs.”
True Life Home Health is certified by the Centers for Medicare & Medicaid Services (CMS). The company offers in home care from qualified health professionals as well as telemonitoring services to connect patients with their care team from the comfort of their own homes. True Life Home Health’s caring and qualified healthcare providers are committed to supporting patients and families who are coping with chronic conditions like Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disease (COPD) and Diabetes, recovering at home from surgery or injuries, and seniors who are aging in place.
ON BEHALF OF THE BOARD “Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: lwelsh@renmarkfinancial.com Tel: (416) 644-2020 or (514) 939-3989 www.renmarkfinancial.com
or CORE Capital Partners at 604-566-9233 or investors@ccpartnersinc.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.
We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the “Company”) does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.
